Related references
Note: Only part of the references are listed.Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
Nick Scott et al.
GUT (2017)
The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments
B. Hajarizadeh et al.
JOURNAL OF HEPATOLOGY (2017)
Direct-acting antivirals for hepatitis C in patient in opioid substitution treatment and heroin assisted treatment: real-life data
N. Scherz et al.
JOURNAL OF HEPATOLOGY (2017)
Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials
J. Grebley et al.
JOURNAL OF HEPATOLOGY (2017)
The PREVAIL Study: intensive models of HCV care for people who inject drugs
A. H. Litwin et al.
JOURNAL OF HEPATOLOGY (2017)
Partial directly observed therapy with ombitasvir/paritaprevir based regimens allows for successful treatment of patients on daily supervised methadone
A. Boyle et al.
JOURNAL OF HEPATOLOGY (2017)
Efficacyand safety of Simeprevir-containing hepatitis C therapy in patients on opiate substitution therapy
J. Dillon et al.
JOURNAL OF HEPATOLOGY (2017)
Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe
A. D. Marshall et al.
JOURNAL OF HEPATOLOGY (2017)
Effectiveness of DAA-based treatment of HCV in active people who inject drugs living in middle income countries (MIC): the results of a prospective cohort study in Tbilisi, Georgia
J. Bouscaillou et al.
JOURNAL OF HEPATOLOGY (2017)
EASL Recommendations on Treatment of Hepatitis C 2016
JOURNAL OF HEPATOLOGY (2017)
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study
E. B. Cunningham et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
Courtney McKnight et al.
JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE (2017)
Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada
Kate Mason et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review
Sahar Bajis et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Phillip Read et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors' Health Network
Leith Morris et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Increased Mortality Among Persons With Chronic Hepatitis C With Moderate or Severe Liver Disease: A Cohort Study
Javier A. Cepeda et al.
CLINICAL INFECTIOUS DISEASES (2017)
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
Jim Young et al.
CLINICAL INFECTIOUS DISEASES (2017)
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection A Systematic Review
Oluwaseun Falade-Nwulia et al.
ANNALS OF INTERNAL MEDICINE (2017)
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
Homie Razavi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration
Meghan D. Morris et al.
CLINICAL INFECTIOUS DISEASES (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Healthcare avoidance by people who inject drugs in Bangkok, Thailand
A. J. Heath et al.
JOURNAL OF PUBLIC HEALTH (2016)
Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy
Angelika Schuetz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy A Randomized Trial
Gregory J. Dore et al.
ANNALS OF INTERNAL MEDICINE (2016)
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Jason Grebely et al.
CLINICAL INFECTIOUS DISEASES (2016)
Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials
Jason Grebely et al.
CLINICAL INFECTIOUS DISEASES (2016)
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
Bryony Simmons et al.
CLINICAL INFECTIOUS DISEASES (2016)
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs
Amanda Weir et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Effect of Registries and Cohort Studies on HCV Treatment
Nezam H. Afdhal et al.
GASTROENTEROLOGY (2016)
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
Natasha K. Martin et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis C reinfection after sustained virological response
Havard Midgard et al.
JOURNAL OF HEPATOLOGY (2016)
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway et al.
LANCET (2016)
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Kate Dolan et al.
LANCET (2016)
Public health and international drug policy
Joanne Csete et al.
LANCET (2016)
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
Louisa Degenhardt et al.
LANCET INFECTIOUS DISEASES (2016)
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Lucy Platt et al.
LANCET INFECTIOUS DISEASES (2016)
Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India
Shruti H. Mehta et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Internalized HIV and Drug Stigmas: Interacting Forces Threatening Health Status and Health Service Utilization Among People with HIV Who Inject Drugs in St. Petersburg, Russia
Sarah K. Calabrese et al.
AIDS AND BEHAVIOR (2016)
Access to HIV treatment and care for people who inject drugs in Kenya: a short report
Andy Guise et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2016)
Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?
Anneke S. de Vos et al.
ADDICTION (2015)
Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens
Z. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
Soumitri Barua et al.
ANNALS OF INTERNAL MEDICINE (2015)
Hepatitis C Virus Therapeutic Development: In Pursuit of Perfectovir
Gregory J. Dore et al.
CLINICAL INFECTIOUS DISEASES (2015)
Excluding people who use drugs or alcohol from access to hepatitis C treatments - Is this fair, given the available data?
Jason Grebely et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C
Juan A. Pineda et al.
JOURNAL OF INFECTION (2015)
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2
V. Saraswat et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3
V. Liakina et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Mixed HCV infection and reinfection in people who inject drugs-impact on therapy
Evan B. Cunningham et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
Viviane D. Lima et al.
PLOS ONE (2015)
Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs
Sarah Larney et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2015)
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
Philip Bruggmann et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2015)
The cost-effectiveness of harm reduction
David P. Wilson et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2015)
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
Seonaid Nolan et al.
ADDICTION (2014)
Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia
Hannah Wilson et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
The Effects of Female Sex, Viral Genotype, and IL28B Genotype on Spontaneous Clearance of Acute Hepatitis C Virus Infection
Jason Grebely et al.
HEPATOLOGY (2014)
The Impact of Injecting Networks on Hepatitis C Transmission and Treatment in People Who Inject Drugs
Margaret Hellard et al.
HEPATOLOGY (2014)
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
Esther J. Aspinall et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011
J. Iversen et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Lower life expectancy among people with an HCV notification: a population-based linkage study
M. Alavi et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P. Bruggmann et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
Roger Williams et al.
LANCET (2014)
Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents
Maryam Alavi et al.
LIVER INTERNATIONAL (2014)
Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study
Bethany White et al.
MEDICAL JOURNAL OF AUSTRALIA (2014)
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
Lucas Wiessing et al.
PLOS ONE (2014)
Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study
Kanna Hayashi et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users
Judith I. Tsui et al.
JAMA INTERNAL MEDICINE (2014)
Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness
Georgina J. MacArthur et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2014)
Injecting on the Island: a qualitative exploration of the service needs of persons who inject drugs in Prince Edward Island, Canada
Jessica M. McCutcheon et al.
HARM REDUCTION JOURNAL (2014)
HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease A Cohort Study
Gregory D. Kirk et al.
ANNALS OF INTERNAL MEDICINE (2013)
Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
Natasha K. Martin et al.
CLINICAL INFECTIOUS DISEASES (2013)
Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive Prevention
Kimberly Page et al.
CLINICAL INFECTIOUS DISEASES (2013)
Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All
Philip Bruggmann et al.
CLINICAL INFECTIOUS DISEASES (2013)
Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis
Esther J. Aspinall et al.
CLINICAL INFECTIOUS DISEASES (2013)
Access to HIV counseling and testing among people who inject drugs in Central Asia: Strategies for improving access and linkages to treatment and care
Assel Terlikbayeva et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Incidence and Prevalence of Hepatitis C in Prisons and Other Closed Settings: Results of a Systematic Review and Meta-Analysis
Sarah Larney et al.
HEPATOLOGY (2013)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin et al.
HEPATOLOGY (2013)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
Magdalena Harris et al.
HARM REDUCTION JOURNAL (2013)
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
Natasha K. Martin et al.
HEPATOLOGY (2012)
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies
Louisa Degenhardt et al.
ADDICTION (2011)
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
Katy M. E. Turner et al.
ADDICTION (2011)
A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs
Holly Hagan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents
J. Grebely et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Paul K. Nelson et al.
LANCET (2011)
What Is Killing People with Hepatitis C Virus Infection?
Jason Grebely et al.
SEMINARS IN LIVER DISEASE (2011)
Vienna Declaration: a call for evidence-based drug policies
Evan Wood et al.
LANCET (2010)
HIV in people who use drugs 2 Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed
Louisa Degenhardt et al.
LANCET (2010)
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward
Daniel Wolfe et al.
LANCET (2010)
Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience
Elise Roy et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
Hla-Hla Thein et al.
AIDS (2008)
Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place
Holly Hagan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs
Libby Topp et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2008)
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Bradley M. Mathers et al.
LANCET (2008)
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users
Charlotte H. S. B. van den Berg et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2007)
Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: A cohort study
JK Champion et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Share Paper
